Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MAIA

Maia Biotechnology (MAIA)

Maia Biotechnology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:MAIA
DateTimeSourceHeadlineSymbolCompany
06/07/202412:31PMBusiness WireMAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent TherapyAMEX:MAIAMaia Biotechnology Inc
06/06/20242:57PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
06/06/202410:07AMBusiness WireMAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer AgentAMEX:MAIAMaia Biotechnology Inc
06/04/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
06/04/20248:41AMBusiness WireMAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung CancerAMEX:MAIAMaia Biotechnology Inc
06/03/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
05/29/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
05/17/20248:37AMBusiness WireMAIA Biotechnology to Present at the BIO International Convention 2024AMEX:MAIAMaia Biotechnology Inc
05/16/20248:37AMBusiness WireMAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual MeetingAMEX:MAIAMaia Biotechnology Inc
05/15/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
05/15/20244:05PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:MAIAMaia Biotechnology Inc
05/14/20244:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:MAIAMaia Biotechnology Inc
05/07/20245:21PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
04/30/20248:08AMBusiness WireMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private PlacementAMEX:MAIAMaia Biotechnology Inc
04/29/20248:08AMBusiness WireMAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private PlacementAMEX:MAIAMaia Biotechnology Inc
04/23/20248:51AMBusiness WireMAIA Biotechnology Announces $1.00 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
04/05/20248:01AMBusiness WireMAIA Biotechnology to Present at Two Investor Conferences in April 2024AMEX:MAIAMaia Biotechnology Inc
03/28/20243:00PMBusiness WireMAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro GuerreroAMEX:MAIAMaia Biotechnology Inc
03/26/20243:00PMBusiness WireMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private PlacementAMEX:MAIAMaia Biotechnology Inc
03/26/20248:01AMBusiness WireMAIA Biotechnology Announces $1.33 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
03/22/20243:00PMBusiness WireMAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
03/21/20243:00PMBusiness WireMAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory BoardAMEX:MAIAMaia Biotechnology Inc
03/08/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
03/07/20249:45AMBusiness WireMAIA Biotechnology to Participate in the 36th Annual ROTH ConferenceAMEX:MAIAMaia Biotechnology Inc
03/06/202411:04AMBusiness WireMAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual MeetingAMEX:MAIAMaia Biotechnology Inc
03/06/20248:48AMBusiness WireMAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer PatientsAMEX:MAIAMaia Biotechnology Inc
03/06/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
03/05/20248:45AMBusiness WireMAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to ShareholdersAMEX:MAIAMaia Biotechnology Inc
02/27/20245:23PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
02/23/20244:17PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
 Showing the most relevant articles for your search:AMEX:MAIA

Your Recent History

Delayed Upgrade Clock